NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) is a publicly traded company in the Unknown sector. Across all available filings, 34 corporate insiders have executed 286 transactions totaling $9.6M, demonstrating a bullish sentiment with $3.1M in net insider flow. The most recent transaction on Nov 27, 2023 involved a transaction of 2,270 shares valued at $0.
No significant insider buying has been recorded for NAVB in the recent period.
No significant insider selling has been recorded for NAVB in the recent period.
Based on recent SEC filings, insider sentiment for NAVB is bullish with an Insider Alignment Score of 66/100 and a net flow of $3.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 34 insiders are actively trading NAVB stock, having executed 286 transactions in the past 90 days. The most active insider is Life Sciences, Llc Platinum-montaur (Executive), who has made 2 transactions totaling $7.8M.
Get notified when executives and directors at NAVB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 27, 2023 | K. Scott John Jr | Executive | Other | 2,270 | $N/A | $0 | |
| Nov 16, 2023 | Stefanelli Jill | Executive | Award | 275,000 | $N/A | $0 | |
| Nov 16, 2023 | Stefanelli Jill | Executive | Award | 416,667 | $N/A | $0 | |
| Nov 16, 2023 | J. Moss Dana | Executive | Award | 416,667 | $N/A | $0 | |
| Nov 16, 2023 | J. Moss Dana | Executive | Award | 200,000 | $N/A | $0 | |
| Nov 10, 2023 | Dais Craig | Executive | Award | 973,633 | $N/A | $0 | |
| Jul 11, 2023 | J. Moss Dana | Executive | Award | 250,000 | $N/A | $0 | |
| Jun 29, 2023 | K. Scott John Jr | Executive | Award | 12,200,000 | $0.09 | $1.1M | Large |
| Jun 8, 2023 | Stefanelli Jill | Executive | Award | 250,000 | $N/A | $0 | |
| Jun 5, 2023 | K. Scott John Jr | Executive | Award | 11,508,672 | $N/A | $0 | |
| Jun 1, 2023 | K. Scott John Jr | Executive | Other | 990 | $N/A | $0 | |
| Nov 30, 2022 | Bhalla Amit | Executive | Award | 1,250 | $N/A | $0 | |
| Nov 30, 2022 | L. Cappello Alexander | Executive | Award | 1,250 | $N/A | $0 | |
| Nov 30, 2022 | K. Scott John Jr | Executive | Award | 1,250 | $N/A | $0 | |
| Nov 30, 2022 | G. Witter Malcolm | Executive | Award | 1,250 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 3 | $7.7M | 37.6% |
Purchase(P) | 51 | $6.4M | 31.0% |
Sale(S) | 21 | $3.2M | 15.8% |
Award(A) | 187 | $1.7M | 8.2% |
Payment(F) | 12 | $1.2M | 5.6% |
Disposition(D) | 7 | $313.6K | 1.5% |
Exercise(M) | 3 | $65.0K | 0.3% |
Gift(G) | 1 | $0 | 0.0% |
Exercise (Options)(X) | 1 | $0 | 0.0% |
Insiders at NAVIDEA BIOPHARMACEUTICALS, INC. are accumulating shares at an accelerated pace. With 34 insiders making 286 transactions totaling $6.4M in purchases versus $3.2M in sales, the net buying activity of $3.1M signals strong executive confidence. Life Sciences, Llc Platinum-montaur (Executive) leads the buying activity with $7.8M in transactions across all time.